Skip to main content
. 2023 Feb 8;10:1032531. doi: 10.3389/fmed.2023.1032531

Table 1.

Data of the 60 patients during enrollment in the phase III trial.

Variables Values
Total numbers 60
Male: Female 52:8
Age (years) 29.8 ± 7.008
HBV DNA (copies/mL) 4.9 × 104 (Range; 1.7 × 103–1.0 × 1013)
Alanine aminotransferase (IU/L) 58.8 ± 31.5
Level of fibrosis F0-F2

The values of different parameters are provided as absolute numbers (numbers of patients observed and male; female ratio), mean and standard deviation (age and ALT), or median and range (HBV DNA). The levels of fibrosis were mild.